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Abstract 
Expression of the vhb gene, encoding hemoglobin from Vitreoscilla stercoraria in several organisms, clearly 
enhances oxygen-dependent product formation. In a previous work, we expressed the vhb gene that encodes 
hemoglobin from V. stercoraria in Amycolatopsis mediterranei, resulting in an increase (oxygen-dependent 
formation) in rifamycin B production. In the present work, we first confirm; by heterologous expression in 
Escherichia coli, that rif-orf5 from the rifamycin biosynthetic gene cluster, really encodes a cytochrome 
P450 enzyme, which is the key step for oxygen incorporation in the final biosynthetic product. Likewise, we 
fused rif-orf5 to the vhb gene, as part of a genetic engineering strategy. The fused genes were used to 
generate an Amycolatopsis mediterranei transformant (Msb-HbCYP5). Interestingly, the fermentation of 
Msb-HbCYP5 manifested 1.5-fold higher rifamicin B production than the transformant with only the 
hemoglobin gene, and 2.2-fold higher than the parental strain.  
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Introduction  
The re-emergence of tuberculosis as a major 
health problem has increased demand for new and 
efficacious antibiotics (Al Yaquobi et al., 2018). 
Rifamycin and its synthetically modified 
derivatives are the principal chemotherapeutic 
agents used for combating tuberculosis and other 
mycobacterial infections (Davies et al., 2008). 
Consequently, much research has focussed on 
improving in vivo production yields of rifamycin, 
and also on using genetic engineering to generate 
rifamycin derivatives (Xu et al., 2018). 
Fortunately, the rifamycin biosynthetic gene 
cluster is one of the best characterized ansamycin 
gene clusters and its biosynthesis is known to 
involve 5 putative cytochrome P450 
monooxygenases (CYP) (rif-orf0, rif-orf4, rif-
orf5, rif-orf13, and rif-orf16), (Kaur et al., 2001).  
 
 
Figure 1. Possible participation of P450 enzyme Rif-Orf5, in the 
oxidative cleavage of rifamycin W (Xu et al., 2005). 
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There are reports of several CYP enzymes 
participating in the macrolide biosynthesis of 
different species of the industrially important 
antibiotic-producing actinomycetes (Bhattacharya 
et al., 2018). In 2004 (Lee et al., 2004), Lee and 
co-workers inactivated one of the five genes from 
the rifamycin gene cluster (rif-orf0), while Xu and 
co-workers inactivated the four remaining genes 
in 2005 (Xu et al., 2005). Their results indicated 
that inactivation of rif-orf5 inhibits rifamycin B 
production and causes the accumulation of 
rifamycin W, a rifamycin analogue that has been 
proposed as a biosynthetic intermediary of 
rifamycin B. This transformation is intimately 
related to oxygen availability in the culture (Mejía 
et al., 2003). Similarly, when the culture reaches 
stationary phase, A. mediterranei, like other 
filamentous microorganisms, exhibits high 
viscosity that provokes low levels of dissolved 
oxygen. As a result, unwanted rifamycins such as 
rifamycin W accumulate in the culture medium. 
In order to solve this problem, we expressed the 
vhb gene encoding hemoglobin from Vitreoscilla 
stercoraria, in A. mediterranei (Guerra et al., 
2008). This strategy successfully improved the 
biosynthesis of the oxygen-dependent product 
rifamycin B. However, even though the 
concentration of rifamycin W decreased, we 
continued to detect some accumulation of this 
biosynthetic intermediary. The main hypothesis 
regarding the remaining rifamycin W suggested 
inner oxygen limitation. We considered the fact 
that despite the inner oxygen increase related to 
the initial strategy, A. mediterranei was driving 
the source in the primary metabolism, thus 
restricting the rifamycin biosynthetic route. To 
solve this problem, we proposed that the inclusion 
of a hemoglobin (vhb) bound to the cytochrome 
P450 (rif-orf5) would facilitate the incorporation 
of oxygen into the biosynthetic rifamycin 
pathway, at the limiting step. Therefore, our first 
objective in the present work was to confirm 
experimentally that the rif-orf5 gene actually 
codes for a cytochrome P450. Secondly, a fusion 
between the vhb gene from V. stercoraria with rif-
orf5, was constructed, cloned into the plasmid 
pULVK2, introduced into A. mediterranei and 
measured its effect on the production of rifamycin 
B. It is apparent that the in vivo antibiotic yields 
improved when the fusion protein transformed the 
bacterial host.  
 
 
Materials and Methods  
 
Microorganisms, media and culture conditions 
 
In the present work, we used the following strains 
of A. mediterranei: Msb2 (a mutant strain from 
M18 ATCC 21789; Mejía et al. 1998); Msb-sag 
(Msb strain containing pUAMSAG1; Priscila et 
al. 2008); S699 strain derived from the ME/83 
ATCC 13685 type strain to obtain the rif-orf5 gen. 
S699 strain was provided by Professor Heinz G. 
Floss (Department of Chemistry, University of 
Washington, Seattle, U.S.A.), who used this strain 
to define the sequence of the rifamycin 
biosynthetic gene cluster. 
 
Escherichia coli DH5α strain as recipient strain 
for plasmids; BL21 pLys was used for the over-
expression of orf5. For storage purposes, A. 
mediterranei strains were either lyophilized, 
frozen at –20 °C or maintained in Bennett agar 
medium. E. coli DH5α and BL21[DE]pLysS 
strains were stored at –80 °C. E. coli strains and 
plasmid containing transformants were grown at 
37 °C in Luria-Bertani medium. Growth media 
were supplemented with 100 µg/mL of ampicillin 
and 50 µg/mL of chloramphenicol. Bennett agar 
was used to grow A. mediterranei, which is a 
medium composed of: glucose 10g, meat extract 
1g, NZ-amine A 2g, yeast extract 1g, and agar 
20g in 1.0 litre tap water. A. mediterranei strains 
were grown in liquid medium containing the 
following components: glucose 20g, soybean 
meal 20g, CaCO3 2.5g, MgSO4.7H2O 0.4g, 
FeSO4.7H2O 0.01g, ZnSO4.7H2O 0.05g and 
CoCl2.6H2O 0.003g in 1.0 litre tap water. Seed 
cultures were grown in a shaking incubator (150 
rpm) at 25 °C for 84 h. The Lee production 
medium was composed of: glucose 120g, bacto-
peptone 10g, yeast extract 5g pH 7.2 in 1.0 litre 
tap water. This medium was inoculated with 20% 
of the seed culture and incubated at 25 °C in a 250 
mL Erlenmeyer flask with 25 mL production 
medium and incubated in a shaking incubator at 
250 rpm. 
 
Primers and plasmids 
 
Table 1. Oligonucleotides used in this work. *Restriction endonuclease cleavage sites are underlined. 
 










Table 2. Plasmids. 
 
Name Description 
pET17b E. coli expression vector (Novagen) 
pULVK2 AAGGCATTCGAATCAGTGATGGTGATGGGACGCCGGCC 
pUAMSAG1 Derivated from pULVK2 with the promoter PermE* linked to the vhb gene 
pGEMrif-orf5 Vector (Promega) with rif-orf5 gene. 





For isolation of RNA, A. mediterranei S699 was 
cultured in 25 mL of the production medium and 
incubated at 25 °C and 250 rpm for 72 h. Every 
24 h, a single flask of culture was removed and 
the contents loaded into centrifuge tubes, where 
biomass was separated by centrifugation at 3,381 
×g for 10 min at 4 °C. We then washed the 
resultant pellet and froze it with liquid nitrogen. 
The pellet from each sample was ground in a 
diethyl pyrocarbonate-treated mortar and pestled 
under liquid nitrogen. Total RNA was isolated 
from about 100 mg of cell lysate using the 
RNeasy Mini Kit (Qiagen Inc., Chatsworth, CA, 
USA). In order to remove DNA contamination 
from the RNA samples, DNAse was added to the 
sample (10 µg/mL). RNA was purified using an 
equal volume of phenol/chloroform. RNA 
samples were then resuspended in 10 – 20 μL 
RNAse free-water and stored at –80 °C. 
 
Cloning, heterologous expression and protein 
isolation.  
 
Purified P450 DNA fragments were cloned into 
the E. coli expression vector pET17b (Novagen). 
Each expression construct was verified by 
complete sequence analysis and then transformed 
into competent E. coli BL21[DE]pLysS 
(Novagen). Expression was performed at 25 °C 
with shaking at 190 rpm for 24 h with the heme 
precursor δ-aminolevulinic acid added to a final 
concentration of 2 mM for optimal CYP 
synthesis. Following expression, E. coli cultures 
were pelleted by centrifugation at 5,000 rpm for 
20 min at 4 °C and then resuspended in 25 ml of 
cold potassium phosphate buffer (pH 7.4, 0.1 M). 
These suspensions were frozen overnight at -80 
°C. Subsequently, the cells were broken by 
thawing at room temperature. The cytosolic 
fraction was separated from the membrane 
fraction by ultracentrifugation at 100,000 x g spin 
for 1 h at 4 °C. Heterologous proteins were 
isolated using a Ni2+-nitriloagarose affinity 
column (Qiagen). 
 
Construction of hemoglobin-P450 fusion 
plasmids, A. mediterranei transformation and 
screening.  
 
The plasmid pULVK2vhb-cyp for the expression 
of the fusion protein VHb-P450 containing the 
DNA of vhb from V. stercoraria linked to the 
cDNA of rif-orf5 was constructed, as described 
below. Plasmid pUAMSAG1 was used as a 
template for the promoter PermE* linked to the 
vhb gene, while pGEMrif-orf5 was used for 
amplifications of rif-orf5 gene. Purified DNA 
fragments (Malhotra et al., 2007) were digested 
with HindIII and EcoRI and cloned directly into 
pULVK2, digested with the same enzymes. We 
identified correct plasmid by enzyme restriction 
mapping and authenticated reading frames related 
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to the expression cassette, by DNA sequencing. A. 
mediterranei strains were made competent and 
transformed by biolistic transfection (vacuum 20 
inches Hg, 6 cm target distance, 900 psi, BioRad 
M5 tungsten particle). The treated cells were 
seeded on plates with Bennett agar. After 
incubation for 6 h at 30 °C, the plates were 
covered with soft agar with erythromycin (10 
µg/ml). Transformants were selected according to 
their ability to grow in this medium. We 
compared the performance of the transformed 
strain with the fused genes of vhb-cyp in A. 
mediterranei and evaluated the production of 
rifamycin B and W production in shake-flasks 
under low aeration (Figure 4). In control 
experiments, this strain was also compared with 
the transformant Msb-sag1 containing 
pUAMSAG1 (vector with vhb gene), Msb-ulvk 
(Msb strain transformed with the empty vector 
pULVK2) and the parental strain. 
 
Protein-Protein Docking and molecular 
simulation  
 
Hemoglobin and cytochrome P450 initial 
structures were built using the iTasser server 
(Zhang et al., 2008) 
(http://zhanglab.ccmb.med.umich.edu/I-
TASSER). We then assigned all hydrogens to 
both structures and minimized energy with 100 
steepest descent (SD) steps using charmm c35b2 
with charmm 27 parameters. The standalone 
Zdock version (Chen et al., 2003) was used to 
dock both structures. All pdb structures generated 
by Zdock were converted to charmm structures, 
using Simulaid software (Mezei et al., 2010) and 
read into charmm. 100 SD minimization steps to 
all hydrogen, keeping heavy atoms fixed first and 
a final 100 SD minimization steps to all atoms 
were applied to each structure to relieve any close 
contact. The structures were sorted according to 
the distance between their carboxyl terminal (C 
atom) of hemoglobin and the cytochrome P450 
amino terminal (N atom). The final structure 
joined both proteins and was soaked in a water 
box of 100 Å3 with 0.15 M KCl. The solvent was 
energy minimized with 50 SD steps followed by 
50 adopted basis Newton-Raphson method, 
keeping protein fixed. A 200 ps NPT molecular 
dynamics simulation was undertaken with 
periodic boundary conditions at 298K with 
NAMD version 2.7b2 (Phillips et al., 2005). All 
structures were visualized using VMD software. 
 
Analytical methods.  
Cell growth was monitored by measuring dry 
weight. The rifamycin B and W contents of the 
culture were determined as previously described 
(Mejía et al., 1998). Reduced carbon monoxide 
difference spectra for identification of cytochrome 
P450 content were measured, following the 
spectral method by Omura and Sato (1964) 
(Sambrook et al., 2001). Biomass samples, 
containing 2 mg of protein per ml of 0.1 M 
phosphate buffer (pH 7.0), were placed in both the 
sample and reference cells. After recording the 
base-line, the content of sample cell was treated 
with various reagents, and the spectral difference 
thereby induced was measured. When CO was 
used, it was carefully bubbled through the sample 
for about 20 seconds; this was sufficient to 
saturate the sample with the gas. Reduction of 
samples with dithionite was done with a few 
milligrams of solid Na2S204. In some experiments 
the sample and reference cells were treated 
differently, and the difference spectrum was 
measured. All spectrophotometric measurements 
were made at room temperature (20-25º). 
 
Results and Discussion 
Confirmation that rif-orf 5 encodes a 
cytochrome P450 
cDNA from rif-orf5 was cloned in pET-17b and 
heterologously expressed in E. coli BL21 pLysS. 
Recombinant protein from this open reading 
frame showed the reduced carbon monoxide 
difference spectra, typical for P450 cytochromes. 
A peak at 420 nm indicating the production of an 
inactive derivative of P450 and another close to 




Figure 2. Reduced carbon monoxide difference spectra of heterologous proteins from rif-orf5 expressed in E. coli 
BL21 pLysS.  The absorbance difference at 450 nm between reduced haemoprotein (Fe2+) versus reduced haemoprotein 
bound to carbon monoxide (Fe2+.CO) was measured using a cytosolic fraction prepared from BL21[DE] pLysS cells 
expressing heterologous proteins. 
 
These results concur with the role for this gene 
defined by Xu and co-workers (2005). This study 
thus confirms that rif-orf5 gene codes for a 
cytochrome P450. Likewise, the accumulation of 
rifamycin W that was observed to result from the 
inactivation of the rif-orf5 gene (Xu et al. 2005), 
implies that this CYP is the key enzyme 
responsible for halting rifamycin B biosynthesis 
with low oxygen transfer (Mejía et al., 2003). This 
result, promoted the design of a chimeric protein, 
consisting of hemoglobin from V. stercoraria 





Molecular modelling and design of a 
hemoglobin-P450 fusion protein 
 
In order to obtain a functional fusion protein, we 
devised an in silico model to predict any possible 
steric impediment.  Hemoglobin and P450 models 
were obtained from 3600 protein complexes with 
Zdock. The best complex was characterised as 
that manifesting lower interaction energy between 
each protein and the shorter distance between the 
hemoglobin carboxyl and the P450 amino 
terminal. The proposed model (Figure 3A) meets 
both requirements and was simulated by 200 ps of 
molecular dynamics to test its stability. The final 
structure (Figure 3B) had a root mean square 
deviation (RMSD) of 2.1 Å (backbone atoms) 
when compared to the initial structure. 
 
Figure 3. Predicted structure of fusion protein consisting of hemoglobin from V. stercoraria linked to the CYP 
domain from rif-orf5. A) Chimeric protein model of V. stercoraria hemoglobin (orange) and Amycolatopsis 
mediterranei cytochrome P450 (green) used in this work. B) Final structure of the molecular dynamics (200 ps). Red 
regions are those with a higher contribution to RMSD when compared against the initial structure and the opposite is 
true for blue regions. Figures were created using VMD 
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The structural effect produced by the insertion of 
glycine amino acids was also studied, which due 
to their small size may function as a hinge 
between both protein molecules. Results from 
geometrical analysis of minimized chimeric 
structures suggest that the presence of a glycine 
hinge, in any size studied, destabilizes the system 
by separating out both molecules. This 
destabilisation may cause the effective 
interchange of material between ligand and active 
sites in the chimeric structure. For all molecular 
conformations obtained from dynamic 
simulations, the chimeric structure without a 
glycine hinge manifested greater molecular 
interaction (data not shown), suggesting a better 
chain coupling for the experimental merged 
protein. Consequently, we decided to link both 
protein molecules directly to the chimeric 
structure, in the absence of a glycine amino acid 
between them. The model proposed for both 
proteins in this work quite adequately resembles 
that of other family members of each protein (data 
not shown). The chimeric protein model proposed 
and studied here was stable during the time 
simulated. Based on this result, we may 
hypothesize that the chimeric protein is stable and 
more importantly is functional in vivo as shown 
here by the experimental data. Using simulation, 
we tested the stability of the chimeric protein, 
over a long period. 
 





















Figure 4. Time course of rifamycin B production. Transformed strain (Msb-sag) with vhb gene (∆). Transformed 
strain (Msb-Lq2) with fused genes (vhb-cyp) (□) and the parental strain (о). 250 ml Flasks containing 70 ml of 






The performance of transformed strain of A. 
mediterranei with the fused genes of vhb-cyp was 
compared with Msb-sag1, Msb-ulvk and parental 
strain. Results revealed that under low aeration 
conditions (Mejía et al., 2003), rifamycin B 
production increased by approximately 42% and 
118% in relation to the Msb-sag strain and parental 
strain, respectively. Same performance was 
observed between Msb-ulvk and parental strain. 
Notably there was no indication of significant 
differences in growth, indicating that specific 
production maintained the same pattern. An 
explanation for these positive results may be that 
two different biochemical properties were linked in 
a single protein, with two-domains containing N-
terminal hemoglobin and C-terminal 
monooxygenase. VHb has an unusually high 
affinity for oxygen brought about by a moderate 
association constant, coupled with an extremely 
low dissociation constant. Although the affinity 
constant of the cytochrome P450 from the rif-orf5 
gene is unknown, results from this study strongly 
suggest a synergistic effect between their activities 
or else some other enhancement of the activity of 
the limiting cytochrome P450. This is corroborated 
by the lower rifamycin W production found in the 
transformed strain. Some other examples of the 
synergistic effect of CYP proteins can be found in 
recent reports. One case is presented by Matthews 
and co-workers, where they fused an alditol oxidase 
from S. coelicolor (AldO) to a cytochrome P450 as 
a chimeric system. With this strategy, the oxidase 
produces the H2O2 needed by the cytochrome, thus 
facilitating its use for efficient fatty acid 
decarboxylation during the production of alkenes 
with industrial importance in biofuels application 
(Matthews, et al., 2017). 
 
Conclusion 
Our results revealed that the beneficial effect of 
VHb expression on biosynthesis of rifamycin can 
be substantially improved by expressing the fusion 
protein (VHb-CYP). The expression of this 
chimeric protein resulted in a 1.5-fold increase in 
rifamycin B production compared to the VHb-
expressing strain and a 2.2-fold increase with 
respect to the parental strain. VHb activity may 
induce a local increase of oxygen concentration; 
possibly increasing the activity of cytochrome P450 
monooxygenase and the fusion construct enhanced 
catalytic efficiency for the biosynthesis of 
rifamycin B. This technique has potential 
application for industrial strains, where oxygen 
transference is important. 
 
Acknowledgements 
The authors would like to thank the Consejo 
Nacional de Ciencia y Tecnología (CONACyT, 
México) for financial support and Laboratorio 
Divisional de Biología Molecular, UAM-I. 
 
Conflict of interest 
On behalf of all authors, the corresponding author 




1. Al Yaquobi, F., Al-Abri, S., Al-Abri, B., 
Al-Abaidani, I., Al-Jardani, A., 
D'Ambrosio, L., ... & Migliori, G. B. 
(2018). Tuberculosis elimination: a dream 
or a reality? The case of Oman. European 
Respiratory Journal, 51(1), 1702027. 
 
2. Chen, R., Tong, W., Mintseris, J., Li, 
L., & Weng, Z. (2003). ZDOCK 
predictions for the CAPRI challenge. 
Proteins: Structure, Function, and 
Bioinformatics, 52(1), 68-73. 
 
3. Davies G.R. and Nuermberger E.L., (2008). 
Pharmacokinetics and pharmacodynamics 
in the development of anti-tuberculosis 
drugs, Tuberculosis., Supple 1, S65-74 
 
4. Priscila, G., Fernández, F. J., Absalón, 
A. E., Suarez, M. D. R., Sainoz, M., 
Barrios-González, J., & Mejía, A. 
(2008). Expression of the bacterial 
hemoglobin gene from Vitreoscilla 
stercoraria increases rifamycin B 
production in Amycolatopsis 
mediterranei. Journal of bioscience and 
bioengineering, 106(5), 493-497. 
 
5. Kaur, H., Cortes, J., Leadlay, P., & Lal, 
R. (2001). Cloning and partial 
characterization of the putative 
rifamycin biosynthetic gene cluster 
from the actinomycete Amycolatopsis 
mediterranei DSM 46095. 
Microbiological research, 156(3), 239-
246. 
 
6. Lee, S. K., Choi, C. Y., Ahn, J. S., Cho, 
J. Y., Park, C. S., & Yoon, Y. J. (2004). 
Identification of a cytochrome P450 
hydroxylase gene involved in rifamycin 
biosynthesis by Amycolatopsis 
mediterranei S699. Journal of 
 8 
microbiology and biotechnology, 14(2), 
356-362. 
 
7. Malhotra, S., & Lal, R. (2007). The 
genus Amycolatopsis: Indigenous 
plasmids, cloning vectors and gene 
transfer systems. Indian journal of 
microbiology, 47(1), 3-14. 
 
8. Matthews, S., Tee, K. L., Rattray, N. J., 
McLean, K. J., Leys, D., Parker, D. A., 
... & Munro, A. W. (2017). Production 
of alkenes and novel secondary 
products by P450 OleTJE using novel 
H2O2‐generating fusion protein 
systems. FEBS letters, 591(5), 737-750. 
 
9. Mejía, A., Barrios-González, J., & 
Viniegra-González, G. (1998). 
Overproduction of rifamycin B by 
Amycolatopsis mediterranei and its 
relationship with the toxic effect of 
barbital on growth. The Journal of 
antibiotics, 51(1), 58-63. 
 
10. Mejía, A., Viniegra-González, G., & 
Barrios-González, J. (2003). 
Biochemical mechanism of the effect of 
barbital on rifamycin B biosynthesis by 
Amycolatopsis mediterranei (M18 
strain). Journal of bioscience and 
bioengineering, 95(3), 288-292. 
 
11. Mezei, M. (2010). Simulaid: a 
simulation facilitator and analysis 
program. Journal of computational 
chemistry, 31(14), 2658-2668. 
 
12. Omura, T. & Sato, R. (1964). The 
carbon monoxide-binding pigment of 
liver microsomes. I. Evidence for its 
hemoprotein nature. J. Biol. Chem. 239, 
2370–2378. 
 
13. Phillips, J. C., Braun, R., Wang, W., 
Gumbart, J., Tajkhorshid, E., Villa, E., 
... & Schulten, K. (2005). Scalable 
molecular dynamics with NAMD. 
Journal of computational chemistry, 
26(16), 1781-1802. 
 
14. S Bhattacharya, S., & S Yadav, J. 
(2018). Microbial P450 Enzymes in 
Bioremediation and Drug Discovery: 
Emerging Potentials and Challenges. 
Current Protein and Peptide Science, 
19(1), 75-86. 
 
15. Sambrook, J., & Russell, D. W. (2001). 
Molecular cloning: a laboratory manual. 
2001. 
 
16. Xu, J., Wan, E., Kim, C. J., Floss, H. 
G., & Mahmud, T. (2005). 
Identification of tailoring genes 
involved in the modification of the 
polyketide backbone of rifamycin B by 
Amycolatopsis mediterranei S699. 
Microbiology, 151(8), 2515-2528. 
 
17. Xu M., Li M., Zhang Y., Zhang H. (2018) 
Optimization of Culture Medium for 
Rifamycin SV Production by 
Amycolatopsis kentuckyensis 22-187. In: 
Liu H., Song C., Ram A. (eds) Advances in 
Applied Biotechnology. ICAB 2016. 
Lecture Notes in Electrical Engineering, 
vol 444. Springer, Singapore 
 
18. Zhang, Y. (2008). I-TASSER server for 
protein 3D structure prediction. BMC 
bioinformatics, 9(1), 40
 9 
 
